Thu, Jan 29, 2015, 2:36 PM EST - U.S. Markets close in 1 hr 24 mins


% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

  • chrtwelve chrtwelve Aug 29, 2011 4:57 PM Flag

    based on a fair multiple

    Based on a fair multiple of trailing earnings, BAC is worth ($16) per share. I don't know why anyone would pay more than negative $8 per share right now. $2 is WAY over the top. Facts are stubborn things.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Seriously, I think it's worth about seven or eight times the $1.48 consensus earnings estimate for next year. About $10 to $12 a share. In a couple of years when the magnitude of the legacy loan problem becomes known, perhaps more like a ten multiple would be warranted.

      There is a limit though as to how far down the stock should be marked because of the bad loans because the nank has already raised $22B in funds the last month, they still have huge non-core assets such as $50B MER and most reputable analysts still aren't looking for much more than about $25B in unreserved bad loans and in the meantime, the company does have that new capital infusion and their operations are profitable.

31.775-0.175(-0.55%)2:35 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.